The size of the Europe Sterilization Services market was worth USD 1.58 billion in 2021. It is further expected to grow at a CAGR of 9.17% and value USD 2.45 billion by 2026.
Y-O-Y growth in the incidence of healthcare-associated infections (HAIs) is significantly accelerating the growth rate of the European sterilization services market. HAIs (healthcare-associated infections) threaten millions of individuals throughout the world during medical treatment. Inadequate hygiene conditions, low-quality infrastructure norms, and a lack of understanding about infection control measures in emerging nations lead to a rise of HAIs. According to the WHO, annual healthcare-related infection costs in Europe are expected to be over US$ 7.7 billion.
Technical advancements have expanded due to a rising senior population pursuing a balanced living and well-established healthcare services in advanced economies. In addition, as the covid-19 epidemic became more widespread, the demand for sterilization services grew. These variables drive the European sterilization services market.
Also contributing significantly to the growth of the sterilization services market in Europe is the growing number of surgical procedures caused by chronic diseases, the rising rate of geriatrics, who are generally ill and in need of continuous care, and the ever-increasing food and beverage industry. The contaminated devices could also contribute to cross-infection. To stop the spread of infectious diseases, sterilization equipment is necessary. Another factor driving the market's growth rate is the growth of the pharmaceutical industry.
However, factors such as the establishment of stringent government policies before the services are allowed for commercial use, a lack of awareness of the need for sterilization, high equipment costs, and saturation in developed regions, on the other hand, prevent the sterilization services market from reaching its full potential.
This research report on the European sterilization services market has been segmented and sub-segmented into the following categories.
By End User:
In 2020, the European market ranked second in accounting for the leading share in the worldwide market, and it is expected to grow significantly during the forecast period. According to the WHO, the cost of healthcare-associated infections in Europe is estimated to be over 7.7 billion dollars per year. Sterilization services are in high demand in this region due to the increased need for disinfection medical devices and the rise in different illnesses in hospitals and clinics. In addition, due to an increasing focus on healthy lifestyles and disease prevention among consumers market is hopeful for sterilization services. The region's substantial share can be ascribed to the growing demand for and acceptance of sterilization services. A growing geriatric population, chronic diseases, the need for sterilization services to combat HAIs, and stringent sterilization regulations will increase the demand for sterilization services in the coming years.
UK sterilization services market held the largest share of the European market in 2020. Scapa Healthcare offers a wide range of sterilization services, including in-house gamma irradiation, microbiology, storage, and product stability.
France follows the UK with a significant share in the European sterilization market. French market trends include an increase in hospital-acquired infections, a rise in surgical procedures requiring high-intensity infection prevention & control, a rise in government awareness programs to protect against high degree infection, and an increase in chronic diseases such as diabetes, cancer, heart obesity, and respiratory disorders.
KEY MARKET PLAYERS:
Companies that play a significant role in the European sterilization services market profiled in the report are STERIS Corporation, Getinge Group, Advanced Sterilization Products, 3M Company, Belimed AG, Cantel Medical Corporation, Anderson Products, Matachana Group, MMM Group, and Sterigenics International Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.3 Ethylene Oxide
5.1.6 Y-o-Y Growth Analysis, By Method
5.1.7 Market Attractiveness Analysis, By Method
5.1.8 Market Share Analysis, By Method
5.2.2 Contract Sterilization Services
5.2.3 Validation Services
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.2 Hospitals and Clinics
5.3.3 Food and Beverage
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Method
126.96.36.199 By Type
188.8.131.52 By End User
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Method
18.104.22.168 By Type
22.214.171.124 By End User
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Method
184.108.40.206 By Type
220.127.116.11 By End User
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 STERIS Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Getinge Group
8.3 Advanced Sterilization Products
8.4 3M Company
8.5 Belimed AG
8.6 Cantel Medical Corporation
8.7 Anderson Products Inc.
8.8 Matachana Group
8.9 MMM Group
8.10 Sterigenics International Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures